Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 8Almirall

02 1Boehringer Ingelheim GmbH

03 2Eli Lilly

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution for injection in a pre-filled pen

Dosage Strength : 250 mg

Packaging : Pre-filled pen 2 2ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

02

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution for injection, solution in pre-filled syringe

Dosage Strength : 250 mg

Packaging : Pre-filled syringe 2 2ml

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Norway

blank

03

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16/11/2023

Application Number : 20221006000045

Regulatory Info : Approved

Registration Country : Sweden

blank

04

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg

Packaging :

Approval Date : 16/11/2023

Application Number : 20221006000038

Regulatory Info : Approved

Registration Country : Sweden

blank

05

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumabum

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date : 30/08/2024

Application Number : 69344

Regulatory Info : Allowed

Registration Country : Switzerland

blank

06

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumabum

Brand Name : Ebglyss

Dosage Form : Solution For Injection

Dosage Strength : 250mg/2ml

Packaging :

Approval Date : 30/08/2024

Application Number : 69460

Regulatory Info : Allowed

Registration Country : Switzerland

blank

07

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Injectable Solution In Pre-Filled Syringe

Dosage Strength : 250MG

Packaging :

Approval Date : 2023-12-21

Application Number : 1231765001

Regulatory Info : Authorized

Registration Country : Spain

blank

08

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

Lebrikizumab

Brand Name : Ebglyss

Dosage Form : Injectable Solution In Pre-Filled Pen

Dosage Strength : 250MG

Packaging :

Approval Date : 2023-12-21

Application Number : 1231765007

Regulatory Info : Authorized

Registration Country : Spain

blank

09

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

IDARUCIZUMAB

Brand Name : PRAXBIND

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 2.5G/50ML

Packaging :

Approval Date :

Application Number : 761025

Regulatory Info :

Registration Country : USA

blank

10

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LEBRIKIZUMAB

Brand Name : EBGLYSS

Dosage Form : SOLUTION

Dosage Strength : 250MG/2ML

Packaging :

Approval Date :

Application Number : 2549123

Regulatory Info : Prescription

Registration Country : Canada

blank

11

Pharma MES 2025
Not Confirmed
arrow
arrow
Pharma MES 2025
Not Confirmed

LEBRIKIZUMAB

Brand Name : EBGLYSS

Dosage Form : SOLUTION

Dosage Strength : 250MG/2ML

Packaging :

Approval Date :

Application Number : 2549131

Regulatory Info : Schedule D

Registration Country : Canada

blank